After successfully wrapping up the Cape Town and Durban shows of his ‘The Sjava 10 Year Celebration Tour’, award-winning singer-songwriter Sjava is now setting his sights on Mpumalanga, with his next ...

On Wednesday, 8 April 2026, Sjava showed off his shoe closet on Instagram, giving fans a glimpse into his lifestyle On Thursday, an X user reshared a screenshot of the musician's Instagram story, ...

Jabulani Hadebe, popularly known as Sjava, has announced the release of his album "Inkanyezi NeziNkanyezi", set to drop on Friday, 30 January 2026. The album marks the last part of the "Inkanyezi" ...

The invitation said: “Two giants unite. Come and experience this historical moment.” It also included an image of two artists walking across the midlands with their backs to the camera. This didn’t ...

At the shisanyama’s Sjava frequent hangout, the price would be about half of that, at most. Despite his elevation to continental superstar, Sjava, whose real name is Jabulani Hadebe, is about as ...

2021 was another remarkable and demanding year for the Transparency International movement. As the pandemic continued to disrupt and reshape global affairs, our international secretariat, chapters and ...

The COVID-19 pandemic set off nearly unprecedented churn in the U.S. labor market. Widespread job losses in the early months of the pandemic gave way to tight labor markets in 2021, driven in part by ...

Music contains so many multitudes that sweeping generalizations about it rarely ring true, but this one still does: There are few things more exciting than an excellent debut album. It’s a thrill to ...

We wrote last week about the record year for special purpose acquisition companies (SPACs) in 2021. We counted over 1,000 new listings last year, and remarkably over 59% were SPACs. Today we explore ...

After a hectic 2020 filing season, the 2021 season appears to be returning to the norm: The deadline to file 2021 federal taxes for most people is Monday, April 18, the IRS announced Monday, as April ...

The FDA’s approval count last year was in line with recent trends, despite the continued impact of COVID-19. The agency’s Center for Drug Evaluation and Research (CDER) approved 50 novel therapeutics ...